Enzon Pharmaceuticals, Inc. (ENZN)
OTCMKTS · Delayed Price · Currency is USD
0.1000
+0.0130 (14.94%)
Mar 31, 2025, 4:00 PM EST

Enzon Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
46.8647.0146.9847.6448.14
Upgrade
Cash & Short-Term Investments
46.8647.0146.9847.6448.14
Upgrade
Cash Growth
-0.33%0.06%-1.38%-1.04%783.99%
Upgrade
Accounts Receivable
---0.030.03
Upgrade
Receivables
---0.030.03
Upgrade
Other Current Assets
0.290.330.410.090.06
Upgrade
Total Current Assets
47.1547.3447.3947.7548.23
Upgrade
Long-Term Deferred Tax Assets
0.020.360.2--
Upgrade
Total Assets
47.1747.747.5947.7548.23
Upgrade
Accounts Payable
0.330.330.330.330.3
Upgrade
Accrued Expenses
0.070.090.090.060.09
Upgrade
Other Current Liabilities
1.281.291.280.010.02
Upgrade
Total Current Liabilities
1.681.711.70.40.41
Upgrade
Total Liabilities
1.681.711.70.40.41
Upgrade
Common Stock
0.740.740.740.740.74
Upgrade
Additional Paid-In Capital
72.1673.4374.7175.9878.01
Upgrade
Retained Earnings
-69.89-70.67-72.04-71.86-71.39
Upgrade
Total Common Equity
3.013.513.414.877.36
Upgrade
Shareholders' Equity
45.4945.9945.8947.3547.82
Upgrade
Total Liabilities & Equity
47.1747.747.5947.7548.23
Upgrade
Net Cash (Debt)
46.8647.0146.9847.6448.14
Upgrade
Net Cash Growth
-0.33%0.06%-1.38%-1.04%783.99%
Upgrade
Net Cash Per Share
0.630.630.630.640.94
Upgrade
Filing Date Shares Outstanding
74.2174.2174.2174.2174.21
Upgrade
Total Common Shares Outstanding
74.2174.2174.2174.2174.21
Upgrade
Working Capital
45.4745.6345.6947.3547.82
Upgrade
Book Value Per Share
0.040.050.050.070.10
Upgrade
Tangible Book Value
3.013.513.414.877.36
Upgrade
Tangible Book Value Per Share
0.040.050.050.070.10
Upgrade
Updated Feb 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.